NCT06193655

Brief Summary

The reliability of advanced echocardiographic and cardiac magnetic resonance (CMR) parameters at repeated measurements is not fully clarified. Test-retest reliability of measurements is crucial for follow-up studies and for clinical monitoring of patients to detect a significant change in ventricular performance, as well as to assess the outcome of various therapies on the size and function of cardiac structures. For echocardiography, the variability of the measurement is more complex, as it depends both on acquisition and reading variability, but also closer to the real life setting than observer variability. Much more limited data exist on the test-retest reliability of right heart parameters, i.e. right ventricle (RV), right atrial (RA) and tricuspid annulus (TA) parameters than on their observer variability and than of the equivalent left-sided parameters. The primary aim of the study is to compare the test-retest reproducibility and agreement of advanced echocardiographic parameters of RV and RA size and function, and of tricuspid annulus (TA) size against the respective parameters obtained by conventional echocardiography and by CMR (where applicable).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
215

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

3 months

First QC Date

August 23, 2023

Last Update Submit

January 4, 2024

Conditions

Keywords

right ventricleright atriumechocardiographycardiac magnetic resonancereproducibility

Outcome Measures

Primary Outcomes (4)

  • Right ventricular ejection fraction test-retest reproducibility

    Agreement and intraclass correlation of 2 sets of repeated measurements 20 minutes apart by echocardiography and CMR

    Through study completion, an average of 6 months

  • Right ventricular longitudinal strain test-retest reproducibility

    Agreement and intraclass correlation of 2 sets of repeated measurements 20 minutes by echocardiography and CMR

    Through study completion, an average of 6 months

  • Right atrial volume test-retest reproducibility

    Agreement and intraclass correlation of 2 sets of repeated measurements 20 minutes by echocardiography and CMR

    Through study completion, an average of 6 months

  • Tricuspid annulus size test-retest reproducibility

    Agreement and intraclass correlation of 2 sets of repeated measurements 20 minutes by echocardiography and CMR

    Through study completion, an average of 6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive patients fulfilling the study enrolment criteria, with clinical indication to perform echocardiography and CMR study, with a relatively fair distribution of RV ejection fraction: normal (25%), mildly reduced (25%), moderately reduced (25%) and severely reduced (25%)

You may qualify if:

  • Age over 18 years old
  • Informed consent

You may not qualify if:

  • Age \<18 years old
  • Pregnancy/breast feeding
  • Tricuspid valve repair/prosthesis
  • Pacemaker or implantable cardiac defibrillator
  • Complex congenital diseases (exceptions: bicuspid aortic valve, atrial septal defect, ventricular septal defect, corrected tetralogy of Fallot)
  • Poor acoustic window
  • Inability to acquire 3D datasets with at least 20 volumes/s
  • Very irregular R-R interval
  • Claustrophobia
  • Acute conditions
  • Hemodynamically instable patients
  • Patients who do not provide consent for the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ventricular Dysfunction, Right

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular Diseases

Study Officials

  • Gianluca Pontone

    Centro Cardiologico Monzino

    STUDY DIRECTOR

Central Study Contacts

Denisa Muraru, Md, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2023

First Posted

January 5, 2024

Study Start

January 1, 2024

Primary Completion

April 1, 2024

Study Completion

September 1, 2024

Last Updated

January 5, 2024

Record last verified: 2024-01